диссертации / 122

111

54.Choy, E.H. Cytokine pathways and joint inflammation in rheumatoid arthritis/.E.H.Choy, G. S. Panayi // N. Engl. J. Med. - 2001. - Vol. 344. - P. 907 -

55.Clague, R.B. The prevalence of serum IgG antibodies to type II collagen in American patients with rheumatoid arthritis/ R. B. Clague, K. Morgan, I. Reynolds et al.// Br. J. Rheumatol. - 1994. - Vol. 33. - № 4. - P. 336 - 338.

56.Coenen, D. Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis/ D. Coenen, P. Verschueren, R. Westhovens et al.// Clin. Chem. – 2007. - Vol. 53. - № 3. - P. 498 – 504.

57.Cohen, J. A coefficient of agreement for nominal scales/ J. Cohen // Educ. Psychol. Measurement. - 1960. - Vol. 20. - P. 37 - 46.

58.Combe, B. EULAR recommendations for themanagement of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)/ B. Combe, R. Landewe, C. Lukas et al. // Annals of the Rheumatic Diseases. - 2007. - Vol. 66. - № 1, P. 34 –

59.Conrad, K. From Pathogenesis to Therapy of Autoimmune Diseases/ K. Conrad, E K .L. Chan, M. J. Fritzler et al // Report on the 9th Dresden Symposium on Autoantibodies held in Dresden. - 2009. - Vol. 6. - P. 279 - 315.

60.Conrad, K. Profiling of rheumatoid arthritis associated autoantibodies/ K. Conrad, D. Roggenbuck, D. Reinhold, T. Dörner // Autoimmun. Rev. - 2010. - №

9.- P. 431 - 435.

61.Cope, A.P. T cells in rheumatoid arthritis./ A .P. Cope // Arthritis. Res Ther. - 2008. - № 10. - Suppl. 1.

62.Courtenay, J. S. Immunisation against heterologous type II collagen induces arthritis in mice/ J. S. Courtenay, M. J. Dallman, A. D. Dayan et al. // Nature. - 1980. - № 283. - P. 666 - 668.

63.Curis, E. Almost all about citrulline in animals/ E. Curis, I. Nicolis et al.// Amino Acids. - 2005. - Vol. 29. - P. 177 – 205.

112

64.Damjanovska, L. The diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis/ L. Damjanovska, M. M Thabet., E. W. N. Levarht et al // Arthritis. Res. Ther. - 2010. - Vol. 69. - № 4. - P.730 - 732.

65.Dejaco, C. Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis/ C. Dejaco, V. Klotz, H. Larcher et al // Arthritis Res. Ther. - 2006. - Vol. 8. - № 4. - P. 119 - 125.

66.de Rycke, L. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extraarticular manifestations/ L. de Rycke, I. Peene, I. Hoffman et al.// Ann. Rheum. Dis. - 2004. - Vol. 63. - P. 1587 – 1593.

67.Despres, N. The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis/ N. Despres, G. Boire, F. J. Lopez-Longo et al.//J. Rheumatol. - 1994. - Vol. 21. - P. 1027 - 1033.

68.Ditzel, H.J. Cloning and expression of a novel human antibody-antigen pair associated with Felty's syndrome/ H. J. Ditzel, Y. Masaki, H. Nielsen et al. // Proc. Nat. Acad. Sci. USA. - 2000. - Vol. 97. - № 16. - P. 9234 - 9239.

69.Dong, H. Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis/ H. Dong, S. E. Strome, E. L. Matteson et al.// J. Clin. Invest. - 2003. - Vol. 111. - № 3. - P. 363 - 370.

70.Dubucquoi, S. Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases/ S. Dubucquoi , E. Solau-Gervais , D. Lefranc et al.// Ann. Rheum. Dis. - 2004. - Vol. 63. - P. 415 - 419.

71.Durrant, L.A. Organisation of the chondrocyte cytoskeleton and its response to changing mechanical conditions in organ culture/ L. A. Durrant, C. W. Archer, M. Benjamin, J. R. Ralphs // J. Anat. - 1999. - Vol. 194. - P. 343 - 353.

72.Egerer, К. A new potential marker for the diagnosis and prognosis of the rheumatoid arthritis – anti-MCV (anti-Mutated - Citrullinated Vimentin)/ К. Egerer, H. Bang, K. Lüthke et al.// Z. Rheumatol. - 2005. - № 64. - P. 8 - 9.

113

73.El-Gabalawy, H.S. Anti-Sa antibodies: prognostic and pathogenetic significance to rheumatoid arthritis/ H. S. El-Gabalawy, J. A. Wilkins // Arthritis Res. Ther.- 2004. - № 6. - P. 86 - 89.

74.Engelmann, R. The anti-mutated citrullinated vimentin response classifies patients with rheumatoid arthritis into broad and narrow responders/ R. Engelmann, J. Brandt, M. Eggert et al.// J. Rheumatol. - 2009. - № 36. - P. 2670 - 2674.

75.Engelmann, R.The impact of HLA-DRB alleles on the subclass titres of antibodies against citrullinated peptides/ R. Engelmann, M. Eggert, G. Neeck, B. Mueller-Hilke // Rheumatology. - 2010. - № 49. - P. 1862 - 1866.

76.Escalona, M. Anti-Sa sera from patients with rheumatoid arthritis contain at least 2 different subpopulations of anti-Sa antibodies/ M. Escalona, F. J. LopezLongo, C. M. Gonzalez et al. // J. Rheumatol. - 2002. - № 29. - P. 2053 - 2060.

77.Fathi, N. A. Diagnostic performance and predictive value of rheumatoid factor, anti-cyclic-citrullinated peptide antibodies and HLA-DRB1 locus genes in rheumatoid arthritis/ N. A. Fathi, A. M. Ezz Eldin, E. Mosad et al. // Int. Arch. Med. - 2008. - № 20.

78.Fiocco, U. Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept./ U. Fiocco, P. Sfriso, F. Oliviero et al.// Autoimmun. Rev. - 2008. - № 8. - P. 76 - 82.

79.Firestein, G. S. Evolving concepts of rheumatoid arthritis./G. S. Firestein // Nature. - 2003. -Vol. 423. - P. 356 - 361.

80.Forslind, K. Prediction of radiological outcome in early RA in clinical practice: role of antibodies to citrullinated peptides (anti-CCP)/ K. Forslind, M. Ahlmen, K. Eberhardt et al.// Ann. Rheum. Dis. - 2004. - Vol. 63. - P. 1090 –1095.

81.Fries, J. Measurement of patient outcome in arthritis / J. Fries, P. Spitz, R. Kraines, H. R. Holman // Arthritis Rheum. - 1980. - Vol. 23. - P. 137 - 145.

82.Gan, S. Q. Organization, structure, and polymorphisms of the human profilaggrin gene/ S. Q. Gan, O. W. McBride, W. W. Idler et al. // Biochemistry. - 1990. - Vol. 29. - P. 9432 – 9440.

114

83.Genevay, S. An eight year prospective study of outcome prediction by antiperinuclear factor and antikeratin antibodies at onset of rheumatoid arthritis/ S. Genevay, G. Hauem, P. Verpillat et al. // Ann. Rheum. Dis. - 2002. - Vol. 6. - P.

734- 736.

84.Gibbons, L. J.Biologic therapy for rheumatoid arthritis. Clinical efficacy and predictors of response/ L. J. Gibbons, K. L. Hyrich // Blodrugs. - 2009. - № 23. - P.

111- 124.

85.Girbal, N. E. The epitopes targeted by the rheumatoid arthritis - associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues/ N. E. Girbal, J. J. Durieux, M. Arnaud et al. // J. Immunol. - 1999. - Vol. 162. - № 1. - P. 585 – 594.

86.Girelli, F. Is Anti Cyclic citrullinatedpeptide a useful laboratory test for the diagnosisof rheumatoid arthritis?/ F. Girelli, F. G. Foschi, E. Bedeschi et al.// European Annals of Allergy and Clinical Immunology. -2004. - vol. 36. - № 4. - P.

127– 130.

87.Goëb, V. Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes/ V. Goëb, M. Thomas-L'Otellier, R. Daveau et al. // Arthritis Res. Ther. - 2009. - Vol. 11. - № 2. - P. 38.

88.Gonzalez-Gronow, M.et al. Analysis of autoantibodies to plasminogen in the serum of patients with rheumatoid arthritis/ M. Gonzalez-Gronow, M. Cuchacovich, D. M. Grigg et al.// J. Mol. Med. (Berl). - 1996. - Vol. 74. - № 8. - P.

463- 469.

89.Goronzy, J. J. Rheumatoid arthritis/ J. J. Goronzy, C. M. Weyand // Immunol. Rev. - 2005. - Vol. 204. - P. 55 - 73.

90.Graudal, N. A. Autoantibodies against interleukin 1alpha in rheumatoid arthritis: association with long term radiographic outcome/ N. A. Graudal, M. Svenson, U. Tarp et al. // Ann. Rheum. Dis. - 2002. - Vol. 61.- № 7. - P. 598 - 602.

91.Greiner, A. Association of anticyclic citrullinated peptide antibodies, anticitrullin antibodies, and IgM and IgA rheumatoid factors with serological

115

parameters of disease activity in rheumatoid arthritis/ A. Greiner, H. Plischke, H. Kellner, R. Gruber// Ann. N Y Acad. Sci. - 2005. - Vol. 1050. - P. 295 - 303.

92.Goldbach-Mansky, R. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset/R. Goldbach-Mansky , J. Lee , A. McCoy et al. // Arthritis Res. - 2000; № 2.- P. 236 - 243.

93.Goulding, N. J.Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosus/ N. J. Goulding, M. R. Podgorski, N. D. Hall et al.// Ann. Rheum. Dis. - 1989. - Vol. 48. - № 10. - P. 843 - 850.

94.Guidelines for immunologic laboratory testing in the rheumatic diseases: an introduction. American college of rheumatology ad hoc committee on immunologic testing guidelines // Arthritis Rheum. – 2002. – Vol. 47. – Р. 429 -

95.Hagiwara, T. Deimination of arginine residues in nucleoplasmin/B23 and histones in HL-90 granulocytes/ T. Hagiwara, K. Nakashima, A. Hirano et al.// Biochem. Biophys. Res. Commun. -2003. - Vol. 290. - P. 979 – 983.

96.Harris, E.D. Rheumatoid Arthritis: pathophisiology and implication for therapy/ E. D. Harris // Engl. J. Med. - 1990. - Vol. 322. - P. 1277 - 1289.

97.Hassfeld, W. Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis/ W. Hassfeld, G. Steiner, K. Hartmuth et al // Arthritis Rheum. - 1989. - Vol. 32. - № 12. - P. 1515 - 1520.

98.Hayem, G. Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis/ G. Hayem, P. Chazerain, B. Combe et al // J. Rheumatol. - 1999. - Vol. 26. - P. 7 - 13.

99.Herold, M. Anti-CCP: history and its usefulness/ M. Herold, V. Boeser, E. Russe, W. Klotz // Clinical and Developmental Immunology. - 2005. - vol. 12. - №

2.- P. 131 – 135.

100.Herrmann, H. Intermediate filaments: from cell architecture to nanomechanics/ H. Herrmann, H. Bär, L. Kreplak et al.// Nature Reviews Molecular Cell Biology. – 2007. - № 8. - P. 562 - 573.

116

101.Hill, A. J. Cutting edge: the conversation of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis associated HLADRB1*0401 MHC class II molecule/ A. J. Hill, S. Southwood, A. Sette et al. // J. Immunol. - 2003. - Vol. 17. - P. 538 - 541.

102.Hoet, R.M. Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin/ R. M. Hoet, A. M. Boerbooms, M. Arends et al.// Ann. Rheum. Dis. -1991. - vol. 50. - P. 611–618.

103.Hoet, R. M. The antiperinuclear factor and antikeratin antibodies in rheumatoid arthritis. Springer Verlag/ R. M. Hoet, W. J. van Venrooij // Rheumatoid Arthritis. - 1992. - P. 299 - 318.

104.Hojo-Nakashima, I. Dynamic expression of peptidylarginine deiminase 2 in human monocytic leukaemia THP-1 cells during macrophage differentiation/ I. Hojo-Nakashima, R. Sato, K. Nakashima et al.// J. Biochem. - 2009. - Vol. 146. - P. 471 - 479.

105.Houssien, D. A.Clinical significanse of IgA rheumatoid factor subclasses in rheumatoid arthritis/ D. A. Houssien, T. Jonsson, E. Davies, et al.// J. Rheumatol. - 1997. -Vol. 24. - P. 2119 - 2122.

106.Hueber, W. Sensitivity and specificity of anti-Sa autoantibodies for rheumatoid arthritis/ W. Hueber, W. Hassfeld, J. S. Smolen et al.// Rheumatology. - 1999. - Vol. 38. - P. 155 - 159.

107.Inagaki, M. Ca2+-dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain/ M. Inagaki, H. Takahara, Y. Nishi et al.// J. Biol. Chem. - 1989. - Vol.

264.- P. 1819 - 1827.

108.Innala, L. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides/ L. Innala, H. Kokkonen, C. Eriksson et al.// J. Rheumatol. - 2008. - Vol. 35. - P. 1002 - 1008.

109.Kastbom, A. Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project)/ A. Kastbom, G.

117

Strandberg, A. Lindroos, T. Skogh //Ann. Rheum. Dis. – 2004. - Vol. 63. - № 9. -

P.1085 – 1089.

110.Katz, M. H. Multivariable analysis: a primer for readers of medical research/ M. H. Katz // Ann. Intern. Med. – 2003. - Vol. 138. - P. 644 - 650.

111.Kim, J. M.When does rheumatoid arthritis begin and why do we need to know?/ J. M. Kim, M. H. Weisman // Arthritis Rheum. - 2000. - Vol. 43. - № 3. -P.

473- 484.

112.Kinloch, A. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis/ A. Kinloch , V. Tatzer , R. Wait et al. // Arthritis. Res. Ther. - 2005. - Vol. 7. - P. 1421 - 1429.

113.Kirfela, J.Keratins: a structural scaffold with emerging functions/ J. Kirfela, T. M. Maginb, J. Reicheltb// Cell. Mol. Life Sci. - 2003. - Vol. 60. - P. 75 - 71.

114.Klareskog, L. Rheumatoid arthritis/ L. Klareskog, A. I. Catrina, S. Paget // Lancet. - 2009. - Vol. 373. - P. 659 - 672.

115.Koivula, M. K. Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis./ M. K. Koivula, M. Heliövaara, H. Rissanen et al.// Ann. Rheum. Dis. - 2012. - Vol. 14. - № 2. – P. 23 - 27.

116.Kroot, E. J. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis/ E. J. Kroot, B. A. De Jong., M. A. Van Leeuwen et al.// Arthritis Rheum. - 2000. - Vol. 43. - P. 1831 - 1835.

117.Kuna, A. T. Mutated citrullinated vimentin antibodies in rheumatoid arthritis./ A. T. Kuna // Clin. Chim. Acta. - 2012. - Vol. 413. - № 1. - P. 66 - 73.

118.Lakos, G. Anti-ciclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope/ G. Lakos, L. Soos, A. Fekete et al.// Ann. Rheum. Dis.

– 2008. -Vol. 67. - Suppl. II, - P. 569.

119.Lee, D. M.Clinical utility of the anti-CCP assay in patients with rheumatic diseases/ D. M. Lee , P. H. Schur // Ann. Rheum. Dis. - 2003. - Vol. 62. - P. 870 -

118

120.Liu, X. The role of anti-mutatedcitrullinated vimentin antibodies in the diagnosis of earlyrheumatoid arthritis/ X. Liu, R. Jia, J. Zhao, Z. Li // Journal of Rheumatology. -2009. - vol. 36. - № 6. - P. 1136 – 1142.

121.Locht, H. Characterisation of autoantibodies to neutrophil granule constituents among patients with reactive arthritis, rheumatoid arthritis and ulcerative colitis/ H. Locht, T. Skogh, A. Wiik // Ann. Rheum. Dis. - 2000. - Vol.

59.- № 11. - P. 898 – 903.

122.López-Longo, F. Anti-Cyclic Citrullinated Peptide versus Anti-Sa Antibodies in Diagnosis of Rheumatoid Arthritis in an Outpatient Clinic for Connective Tissue Disease and Spondyloarthritis/ F. López-Longo, M. Rodríguez-Mahou, S. Sánchez-Ramon et al. // J. Rheumatol. – 2006. - Vol. 33. - P. 1476 – 1481.

123.Luime, J. J. Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review/ J. J. Luime , E. M. Colin , J. M. Hazes , E. Lubberts // Ann. Rheum. Dis. - 2010. - Vol. 69. - P. 337 - 344.

124.Lundberg, K. Rheumatoid arthritis-specific autoantibodies to an immunodominant epitope in citrullinated a-enolase cross-react with bacterial enolase,” in Proceedings of the ACR/ K. Lundberg //Annual Scientific Meeting. - 2007. - abstract № 1303.

125.Machold, K. P. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease./ K. P. Machold, T. A. Stamm, V. P. Nell et al. // Rheumatology (Oxford). - 2007. - Vol. 46. - P. 342 - 349.

126.Makrygiannakis, D. Citrullination is an inflammation-dependent process/ D. Makrygiannakis, E. Klint, I. Lundberg et al. // Ann. Rheum. Dis. - 2006. - Vol. 65. - P. 1219 – 1222.

127.Manole, Cojocaru. Clinical relevance of antikeratin antibodies in rheumatoid arthritis and symmetric polyarthritis associated with hepatitis C infection/ Manole Cojocaru, Inimioara Mihaela Cojocaru, Simona Alexandara Iacob // Jugoslov. Med. Biohem. -2006. - Vol. 25. - P. 17 – 20.

119

128.Marinova-Mutafchieva, L. Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint/ L. Marinova-Mutafchieva, P. Taylor, K. Funa et al. // Arthritis. Rheum. - 2000. - Vol.

43.- P. 2046 - 2055.

129.Marnell, L. L. Anti-class II beta-chain antibodies in the serum and synovial fluid of rheumatoid arthritis patients/ L .L. Marnell, R. P. Searles, S. M. Savage et al. // Clin. Immunol. Immunopathol. - 1990. - Vol. 55. -P. 263 - 272.

130.Masson-Bessière, C. The major synovial targets of the rheumatoid arthritisspecific antifilaggrin autoantibodies are deiminated forms of the alphaand betachains of fibrin/ C. Masson-Bessière , M. Sebbag , E. Girbal-Neuhauser et al. // J. Immunol. - 2001. - Vol. 166. - P. 4177 - 4184.

131.Matsson, L. Antibodies against citrullinated vimentin in rheumatoid arthritis/ L. Matsson, M. Mullazehi, M. Wick et al.// Arthritis Rheum. - 2008. - Vol. 58. - P.

36- 45.

132.Matsumoto, I. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease/ I. Matsumoto, M. Maccioni, D. M. Lee et al.// Nat. Immunol. – 2002. - Vol. 3. - № 4. - P. 360 - 365.

133.Matsuo, K. Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach./ K. Matsuo, Y. Xiang, H. Nakamura et al. // Arthritis. Res. Ther. - 2006. - Vol. 8. - № 6. - P. 175.

134.McGonale, D. A proposed classification of the immunological diseases/ D. McGonale, M. F. McDermott // PLoS Med. - 2006. - Vol. 3. - P. 1242 – 1248.

135.Mediwake, R. Use of anticitrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis/ R. Mediwake, D. A. Isenberg, G. A. Schellekens, et al // Ann. Rheum. Dis. - 2001. - Vol. 60. - P. 67 – 68.

136.Menard, H. Insights into rheumatoid arthritis derived from the Sa immune system/ H. Menard, E. Lapointe, M. Rochdi, et al.// Arthritis Res. - 2000. - Vol. 2. - P. 429 - 432.

120

137.Meyer, O. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage/ O. Meyer , C. Labarre , M. Dougados et al. // Ann. Rheum. Dis. - 2003. - Vol. 62. - P. 120 - 126.

138.Mewar, D. Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis/ D. Mewar, A. Coote, D. J. Moore et al. // Arthritis Res. Ther. - 2006. - Vol. 8. - P. 128.

139.Mewar, D. Antiferritin antibodies discovered by phage display expression cloning are associated with radiographic damage in rheumatoid arthritis/ D. Mewar, D. J. Moore, S. Young-Min et al.// Arthritis Rheum. - 2005. - Vol. 52. - №

12.- P. 3868 - 3872.

140.Mimori, T. Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases/ T. Mimori, K. Suganuma, Y. Tanami et al. // Proc. Natl. Acad. Sci. USA. - 1995. - Vol. 92. - № 16. - P. 7267 - 7271.

141.Mutlu, N. Comparative erformance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis/ N. Mutlu, M. Bicakcigil, D. A. Tasan et al. // Journal of Rheumatology. -2009. - vol. 36. - № 3. - P. 491 – 500.

142.Nell, V. P. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis/ V. P. Nell , K. P. Machold , T. A. Stamm . et al. // Ann. Rheum. Dis. - 2005. - Vol. 64. - P. 1731 - 1736.

143.Nielen, M. M. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis/ M. M. Nielen, A. R. van der Horst , D. van Schaardenburg et al. // Ann. Rheum. Dis. - 2005. - Vol. 64. - P. 1199 - 1204.

144.Nielen, M. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors/ M. Nielen, D. van Schaardenburg, H. Reesink et al.//Arthritis Rheum.- 2004. - Vol. 50.- P. 380 – 386.